Methode Electronics Inc 8-K, filed Dec 18, 2025
Methode Electronics Inc (MEI)
About this 8-K
Methode Electronics Inc filed this 8-K on December 18, 2025, reporting on events of December 16, 2025.
Items reported
- Item 5.02: Director or officer change, or executive pay
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
|
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Change of Control Agreements
On December 16, 2025, Methode Electronics, Inc. (“Methode”) amended the Change in Control Agreements with Laura Kowalchik, Chief Financial Officer, Lars Ullrich, Senior Vice President, Global Automotive Business, John Erwin, Chief Procurement and EHS Officer, and Kerry Vyverberg, General Counsel (the “Amendments”). The Amendments reduce the duration of COBRA continuation coverage for the executives from twenty-four months to eighteen months.
The Amendments were approved by Methode’s Compensation Committee in connection with its annual review of the executive Change in Control Agreements.
The foregoing description of the Amendments is a summary of the terms contained therein and is qualified in its entirety by reference to the terms of the Form of Amendment to Change in Control Agreement, which is attached as Exhibit 10.1 to this Current Report on Form 8-K, and is incorporated herein by reference.
Deferred Compensation Plan
On December 17, 2025, Methode’s Board of Directors approved the termination of the Deferred Compensation Plan effective as of December 31, 2025.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
10.1 Form of Amendment to Change in Control Agreement
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
Methode Electronics, Inc. |
|
|
|
|
Date: |
December 18, 2025 |
By: |
/s/ Laura Kowalchik |
|
|
|
Laura Kowalchik |
Exhibit 10.1
FORM OF AMENDMENT TO CHANGE IN CONTROL AGREEMENT
This Amendment to Change in Control Agreement (the “Amendment”) is dated as of December 17, 2025, between Methode Electronics, Inc., a Delaware corporation (the “Company”), and [ ] (“Employee”).
WITNESSETH:
WHEREAS, the Company and the Employee are party to a Change of Control Agreement (the “Change in Control Agreement”); and
WHEREAS, the parties desire to amend the Change in Control Agreement as set forth herein.
NOW, THEREFORE, it is hereby agreed by and between the parties, for good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, as follows:
1.3 Continued Health Benefits. If Employee timely and properly elects continuation health care coverage pursuant to the Company’s group health care plan, the Company will pay on Employee’s behalf the COBRA premiums for such COBRA continuation coverage (or cash in lieu thereof if COBRA is no longer available to Employee) for a designated period ending on the earlier of (i) eighteen (18) months following Employee’s Date of Termination, or (ii) the date Employee first becomes eligible for coverage under another employer’s group health plan (such period referred to as the “COBRA Subsidy Period”). The Company will treat the cost of such coverage to Employee as taxable income for federal income tax purposes to the extent required by law. Employee shall promptly inform the Company in writing if and when Employee obtains or becomes eligible for any other health care coverage from another employer of Employee. Employee shall be responsible for the full unsubsidized costs of COBRA coverage after the COBRA Subsidy Period.
IN WITNESS WHEREOF, the parties hereto have executed this Amendment on the day and year first written above.
METHODE ELECTRONICS, INC.
By:
Jon DeGaynor
Its: Chief Executive Officer
EMPLOYEE:
Name: [ ]
-2-